...telomerase reverse transcriptase (TERT) and the tumour suppressor TP53 are emerging as feasible tools for molecular prognostication of DTC. In the recent years,
mutations of the TERT promoter, with the 1,295,228 C>T (C228T) and the 1,295,250 C>T (C250T) being the most commonly
detected, have represe ~~~